ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!
Search for

UniProtKB/Swiss-Prot entry Q8V294


[Entry info] [Name and origin] [References] [Comments] [Cross-references] [Keywords] [Features] [Sequence] [Tools]

Note: most headings are clickable, even if they don't appear as links. They link to the user manual or other documents.
Entry information
Entry name POLN_EEVVC
Primary accession number Q8V294
Secondary accession numbers Q5IBC3 Q8UYH5 Q8V295
Integrated into Swiss-Prot on April 4, 2006
Sequence was last modified on April 4, 2006 (Sequence version 2)
Annotations were last modified on    November 4, 2008 (Entry version 44)
Name and origin of the protein
Protein name Non-structural polyprotein
Synonyms Polyprotein nsP1234
P1234
Contains P123
P123'
mRNA-capping enzyme nsP1
     (EC 2.1.1.-)
     (EC 2.7.7.-)
     (Non-structural protein 1)
Protease/triphosphatase/NTPase/helicase nsP2
     (EC 3.4.22.-)
     (EC 3.1.3.33)
     (EC 3.6.1.15)
     (EC 3.6.1.-)
     (Non-structural protein 2)
     (nsP2)
Non-structural protein 3
     (nsP3)
Non-structural protein 3'
     (nsP3')
RNA-directed RNA polymerase nsP4
     (EC 2.7.7.48)
     (Non-structural protein 4)
     (nsP4)
Gene name None
From
Venezuelan equine encephalitis virus (strain CPA201) (VEEV) [TaxID: 376610] 
Taxonomy Viruses; ssRNA positive-strand viruses, no DNA stage; Togaviridae; Alphavirus; VEEV complex.
Virus hosts Bos taurus (Bovine) [TaxID: 9913]
Didelphis marsupialis (Southern opossum) [TaxID: 9268]
Equus asinus (Donkey) [TaxID: 9793]
Equus caballus (Horse) [TaxID: 9796]
Homo sapiens (Human) [TaxID: 9606]
Melanoconion [TaxID: 53535]
Philander opossum (Gray four-eyed opossum) [TaxID: 9272]
Proechimys [TaxID: 10162]
Sigmodon hispidus (Hispid cotton rat) [TaxID: 42415]
Protein existence 2: Evidence at transcript level;
References
[1]
NUCLEOTIDE SEQUENCE [GENOMIC RNA].
STRAIN=CPA152, CPA201, OAX131, and OAX142;
DOI=10.1128/JVI.76.4.1718-1730.2002; PubMed=11799167 [NCBI, ExPASy, EBI, Israel, Japan]
Brault A.C., Powers A.M., Holmes E.C., Woelk C.H., Weaver S.C.;
"Positively charged amino acid substitutions in the e2 envelope glycoprotein are associated with the emergence of venezuelan equine encephalitis virus.";
J. Virol. 76:1718-1730(2002).
[2]
NUCLEOTIDE SEQUENCE [GENOMIC RNA].
STRAIN=MX01-22;
Weaver S.C.;
"Venezuelan equine encephalitis virus from Southern Mexico.";
Submitted (NOV-2004) to the EMBL/GenBank/DDBJ databases.
Comments
  • FUNCTION: P123 and P123' are short-lived polyproteins, accumulating during early stage of infection. P123 is directly translated from the genome, whereas P123' is a product of the cleavage of P1234. They localize the viral replication complex to the cytoplasmic surface of modified endosomes and lysosomes. By interacting with nsP4, they start viral genome replication into antigenome. After these early events, P123 and P123' are cleaved sequentially into nsP1, nsP2 and nsP3/nsP3'. This sequence of delayed processing would allow correct assembly and membrane association of the RNA polymerase complex (By similarity).
  • FUNCTION: nsP1 is a cytoplasmic capping enzyme. This function is necessary since all viral RNAs are synthesized in the cytoplasm, and host capping enzymes are restricted to the nucleus. The enzymatic reaction involves a covalent link between 7-methyl-GMP and nsP1, whereas eukaryotic capping enzymes form a covalent complex only with GMP. nsP1 capping would consist in the following reactions: GTP is first methylated and then forms the m7GMp-nsP1 complex, from which 7-methyl-GMP complex is transferred to the mRNA to create the cap structure. Palmitoylated nsP1 is remodeling host cell cytoskeleton, and induces filopodium-like structure formation at the surface of host cell (By similarity).
  • FUNCTION: nsP2 has two separate domain with different biological activities. The N-terminal section is part of the RNA polymerase complex and has RNA trisphosphatase and RNA helicase activity. The C-terminal section harbors a protease that specifically cleaves and releases the four mature proteins (By similarity).
  • FUNCTION: nsP3 and nsP3' are essential for minus strand and subgenomic 26S mRNA synthesis (By similarity).
  • FUNCTION: nsP4 is a RNA dependent RNA polymerase. It replicates genomic and antigenomic RNA by recognizing replications specific signals. Transcribes also a 26S subgenomic mRNA by initiating RNA synthesis internally on antigenomic RNA. This 26S mRNA encodes for structural proteins. nsP4 is a short-lived protein regulated by several ways: the opal codon readthrough and degradation by ubiquitin pathway (By similarity).
  • CATALYTIC ACTIVITY: S-adenosyl-L-methionine + GTP = m7GTP.
  • CATALYTIC ACTIVITY: m7GTP + (5')pp-Pur-mRNA = diphosphate + m7G(5')ppp-Pur-mRNA.
  • CATALYTIC ACTIVITY: (5')ppp-mRNA + H2O = (5')pp-mRNA + phosphate.
  • CATALYTIC ACTIVITY: A 5'-phosphopolynucleotide + H2O = a polynucleotide + phosphate.
  • CATALYTIC ACTIVITY: NTP + H2O = NDP + phosphate.
  • CATALYTIC ACTIVITY: Nucleoside triphosphate + RNA(n) = diphosphate + RNA(n+1).
  • SUBUNIT: P123 interacts with nsP4; nsP1, nsP2, nsP3 and nsP4 interact with each other, and with uncharacterized host factors (By similarity).
  • SUBCELLULAR LOCATION: Non-structural polyprotein: Endosome membrane; Peripheral membrane protein; Cytoplasmic side (By similarity). Lysosome membrane; Peripheral membrane protein; Cytoplasmic side (By similarity). Note=Located on the cytoplasmic surface of modified endosomes and lysosomes, also called cytopathic vacuoles type I (CPVI). These vacuoles contain numerous small circular invaginations (spherules) which may be the sites of RNA synthesis.
  • SUBCELLULAR LOCATION: P123: Endosome membrane; Peripheral membrane protein; Cytoplasmic side (By similarity). Lysosome membrane; Peripheral membrane protein; Cytoplasmic side (By similarity).
  • SUBCELLULAR LOCATION: P123': Endosome membrane; Peripheral membrane protein; Cytoplasmic side (By similarity). Lysosome membrane; Peripheral membrane protein; Cytoplasmic side (By similarity).
  • SUBCELLULAR LOCATION: mRNA-capping enzyme nsP1: Endosome membrane; Peripheral membrane protein; Cytoplasmic side (By similarity). Lysosome membrane; Peripheral membrane protein; Cytoplasmic side (By similarity). Cell membrane; Peripheral membrane protein; Cytoplasmic side (By similarity). Cell projection, filopodium (By similarity). Note=In the late phase of infection, the polyprotein is quickly cleaved before localization to cellular membranes. Then a fraction of nsP1 localizes to the inner surface of the plasma membrane and its filopodial extensions (By similarity).
  • SUBCELLULAR LOCATION: Protease/triphosphatase/NTPase/helicase nsP2: Endosome membrane; Peripheral membrane protein; Cytoplasmic side (By similarity). Lysosome membrane; Peripheral membrane protein; Cytoplasmic side (By similarity). Nucleus (By similarity). Note=In the late phase of infection, the polyprotein is quickly cleaved before localization to cellular membranes. Then approximately half of nsP2 is found in the nucleus (By similarity).
  • SUBCELLULAR LOCATION: Non-structural protein 3: Endosome membrane; Peripheral membrane protein; Cytoplasmic side (By similarity). Lysosome membrane; Peripheral membrane protein; Cytoplasmic side (By similarity). Cytoplasm (By similarity). Note=In the late phase of infection, the polyprotein is quickly cleaved before localization to cellular membranes. Then nsP3 and nsP3' seems to aggregate in cytoplasm (By similarity).
  • SUBCELLULAR LOCATION: Non-structural protein 3': Endosome membrane; Peripheral membrane protein; Cytoplasmic side (By similarity). Lysosome membrane; Peripheral membrane protein; Cytoplasmic side (By similarity). Cytoplasm (By similarity). Note=In the late phase of infection, the polyprotein is quickly cleaved before localization to cellular membranes. Then nsP3 and nsP3' seems to aggregate in cytoplasm (By similarity).
  • SUBCELLULAR LOCATION: RNA-directed RNA polymerase nsP4: Endosome membrane; Peripheral membrane protein; Cytoplasmic side (By similarity). Lysosome membrane; Peripheral membrane protein; Cytoplasmic side (By similarity).
  • INDUCTION: Viral replication produces dsRNA in the late phase of infection, resulting in a strong activation of host EIF2AK2/PKR, leading to almost complete phosphorylation of EIF2A. This inactivates completely cellular translation initiation, resulting in a dramatic shutoff of proteins synthesis. Translation of viral non-structural polyprotein and all cellular proteins are stopped in infected cell between 2 and 4 hours post infection. Only the 26S mRNA is still translated into viral structural proteins, presumably through a unique mechanism of enhancer element which counteract the translation inhibition mediated by EIF2A. By doing this, the virus uses the cellular defense for its own advantage: shutoff of cellular translation allows to produce big amounts of structural proteins needed for the virus to bud out of the doomed cell.
  • PTM: Specific enzymatic cleavages in vivo yield mature proteins. The polyprotein is synthesized as P123, or P1234 by stop codon readthrough. These polyproteins are processed differently depending on the stage of infection. In early stages, P1234 is first cleaved in trans, through its nsP2 protease activity, releasing P123' and nsP4. P123/P123' and nsP4 start to replicate the viral genome into its antigenome. After these early events, nsP1 is cleaved in cis by nsP2 protease, releasing the P23/P23' polyprotein. Cleavage of nsP1 expose an "activator" at the N-terminus of P23/P23' which induces its cleavage into nsP2 and nsP3 by the viral protease. This sequence of delayed processing would allow correct assembly and membrane association of the RNA-polymerase complex. In the late stage of infection, the presence of free nsP2 in the cytoplasm cleaves P1234 quickly into P12 and P34, then into the four nsP (By similarity).
  • PTM: nsP1 is palmitoylated by host (By similarity).
  • PTM: nsP4 is ubiquitinated; targets the protein for rapid degradation via the ubiquitin system (By similarity).
  • MISCELLANEOUS: The genome encodes for P123, but readthrough of a terminator codon UGA occurs between the codons for Gln-1883 and Arg-1884. This readthrough produces P1234, cleaved quickly by nsP2 into P123' and nsP4. Further processing of p123' gives nsP1, nsP2 and nsP3' which is 6 amino-acids longer than nsP3 since the cleavage site is after the readthrough. This unusual molecular mechanism ensures that few nsP4 are produced compared to other non-structural proteins. Mutant viruses with no alternative termination site grow significantly slower than wild-type virus.
  • SIMILARITY: Contains 1 Macro domain.
  • SIMILARITY: Contains 1 peptidase C9 domain [view classification].
  • SIMILARITY: Contains 1 RdRp catalytic domain.
Copyright
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms. Distributed under the Creative Commons Attribution-NoDerivs License.
Cross-references
Sequence databases
EMBL
AF448535; AAL47146.1; -; Genomic_RNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AF448536; AAL47148.1; -; Genomic_RNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AF448537; AAL47150.1; -; Genomic_RNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AF448538; AAL47152.1; -; Genomic_RNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AY823299; AAW30005.1; -; Genomic_RNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
3D structure databases
HSSP P08411; 1FW5. [HSSP ENTRY / PDB]
SMR Q8V294; 1003-1322.
ModBase Q8V294.
Ontologies
GO
GO:0042995; Cellular component: cell projection (inferred from electronic annotation from UniProtKB-KW).
GO:0005768; Cellular component: endosome (inferred from electronic annotation from UniProtKB-KW).
GO:0005765; Cellular component: lysosomal membrane (inferred from electronic annotation from UniProtKB-SubCell).
GO:0005634; Cellular component: nucleus (inferred from electronic annotation from UniProtKB-KW).
GO:0005886; Cellular component: plasma membrane (inferred from electronic annotation from UniProtKB-KW).
GO:0005524; Molecular function: ATP binding (inferred from electronic annotation from UniProtKB-KW).
GO:0008168; Molecular function: methyltransferase activity (inferred from electronic annotation from UniProtKB-KW).
GO:0004651; Molecular function: polynucleotide 5'-phosphatase activity (inferred from electronic annotation from EC).
GO:0006370; Biological process: mRNA capping (inferred from electronic annotation from UniProtKB-KW).
GO:0006410; Biological process: transcription, RNA-dependent (inferred from electronic annotation from UniProtKB-KW).
QuickGo view.
Family and domain databases
InterPro IPR002589; A1pp.
IPR002620; Peptidase_C9.
IPR001788; RNA-dep_RNA_pol_vir-typ.
IPR000606; RNA_helicase1_vir.
IPR007094; RNA_pol_PSvir.
Graphical view of domain structure.
Pfam PF01661; A1pp; 1.
PF01707; Peptidase_C9; 1.
PF00978; RdRP_2; 1.
PF01443; Viral_helicase1; 1.
Pfam graphical view of domain structure.
SMART SM00506; A1pp; 1.
SMART graphical view of domain structure.
PROSITE PS51154; MACRO; 1.
PS50507; RDRP_SSRNA_POS; 1.
PROSITE graphical view of domain structure (profiles).
BLOCKS Q8V294.
ProtoNet Q8V294.
Other
UniRef View cluster of proteins with at least 50% / 90% / 100% identity.
Keywords
ATP-binding; Cell membrane; Cell projection; Cytoplasm; Endosome; Helicase; Hydrolase; Lipoprotein; Lysosome; Membrane; Methyltransferase; mRNA capping; mRNA processing; Multifunctional enzyme; Nucleotide-binding; Nucleotidyltransferase; Nucleus; Palmitate; Protease; RNA replication; RNA-binding; RNA-directed RNA polymerase; Thiol protease; Transferase; Ubl conjugation.
Features
SEVIEWER logo Feature table viewer FT aligner logo Feature aligner
KeyFrom    To Length Description FTId
CHAIN   1   2496  2496     Non-structural polyprotein. PRO_0000308388
CHAIN   1   1890  1890     P123'. PRO_0000232102
CHAIN   1   1883  1883     P123. PRO_0000232103
CHAIN   1    535  535     mRNA-capping enzyme nsP1. PRO_0000232104
CHAIN   536   1329  794     Protease/triphosphatase/NTPase/helicase nsP2. PRO_0000232105
CHAIN   1330   1890  561     Non-structural protein 3'. PRO_0000232106
CHAIN   1330   1883  554     Non-structural protein 3. PRO_0000232107
CHAIN   1891   2496  606     RNA-directed RNA polymerase nsP4. PRO_0000232108
DOMAIN   963   1163  201     Peptidase C9. 
DOMAIN   1330   1489  160     Macro. 
DOMAIN   2253   2368  116     RdRp catalytic. 
NP_BIND   721    728  8     ATP (Potential). 
REGION   244    263  20     nsP1 membrane-binding (By similarity). 
REGION   1004   1023  20     Nucleolus localization signal (By similarity). 
MOTIF   1179   1183  5     Nuclear localization signal (By similarity). 
ACT_SITE   1012   1012        For cysteine protease nsP2 activity (By similarity). 
ACT_SITE   1081   1081        For cysteine protease nsP2 activity (By similarity). 
SITE   535    536  2     Cleavage; by nsP2 (By similarity). 
SITE   1329   1330  2     Cleavage; by nsP2 (By similarity). 
SITE   1889   1890  2     Cleavage; by nsP2 (By similarity). 
LIPID   419    419        S-palmitoyl cysteine; by host (By similarity). 
VARIANT   167    167  1     N -> T (in strain: MX01-22). 
VARIANT   487    487  1     I -> V (in strain: CPA152, MX01-22, OAX131 and OAX142). 
VARIANT   1095   1095  1     K -> Q (in strain: CPA152, MX01-22, OAX131 and OAX142). 
VARIANT   1664   1664  1     S -> P (in strain: MX01-22). 
VARIANT   1672   1672  1     L -> S (in strain: CPA152, MX01-22, OAX131 and OAX142). 
VARIANT   1704   1704  1     A -> DT (in strain: CPA152, OAX131, OAX142 and MX01-22). 
VARIANT   1708   1708  1     V -> E (in strain: OAX131). 
VARIANT   1821   1821  1     M -> R (in strain: OAX131). 
Sequence information
Length: 2496 AA [This is the length of the unprocessed precursor] Molecular weight: 278766 Da [This is the MW of the unprocessed precursor] CRC64: 41B3BFADC6E098E2 [This is a checksum on the sequence]
        10         20         30         40         50         60 
MEKVHVDIEE DSPFLRALQR SFPQFEVEAK QVTDNDHANA RAFSHLASKL IETEVEPSDT 

        70         80         90        100        110        120 
ILDIGSAPAR RMYSKHKYHC ICPMKCAEDP DRLFKYAAKL KKNCKDITDK ELDKKMKELA 

       130        140        150        160        170        180 
EVMSDPDLET ETICLHDDET CRFEGQVAVY QDVYAVDGPT SLYHQANKGV RVAYWIGFDT 

       190        200        210        220        230        240 
TPFMFKNLAG AYPSYSTNWA DETVLTARNI GLCSSDVMER SRRGMSILRK KFLKPSNNVL 

       250        260        270        280        290        300 
FSVGSTIYHE KRDLLRSWHL PSVFHLRGKQ NYTCRCETIV SCDGYVVKRI AISPGLYGKP 

       310        320        330        340        350        360 
SGYAATMHRE GFLCCKVTDT LDGERVSFPV CTYVPATLCD QMTGILATDV SADDAQKLLV 

       370        380        390        400        410        420 
GLNQRIVVNG RTQRNTNTMK NYLLPVVAQA FARWAKEYKE DQEDERPLGL RDRQLVMGCC 

       430        440        450        460        470        480 
WAFRKHKITS VYKRPDTQTI IKVNSDFHSF VLPRIGSNTL EIGLRTRIRK LLEEPVDRPP 

       490        500        510        520        530        540 
LITADDIQEA KNAADEAKEV KEAEELRAAL PPLSADVEEP ALEADVDLML QEAGAGSVET 

       550        560        570        580        590        600 
PRGLIKVTSY AGEDKIGSYA VLSPQAVLRS EKLTCIHPLA EQVIVITHSG RKGRYAVEPY 

       610        620        630        640        650        660 
HGKVVVPEGQ AIPVQDFQAL SESATIVYNE REFVNRYLHH IATHGGALNT DEEYYRVVKP 

       670        680        690        700        710        720 
SEHEGEYLYD IDKKQCVKKE LVSGLGLTGE LVDPPFHEFA YESLRTRPAA PYQVPTIGVY 

       730        740        750        760        770        780 
GVPGSGKSGI IKSAVTKKDL VVSAKKENCA EIIRDVKKMK GLDVNARTVD SVLLNGCKHP 

       790        800        810        820        830        840 
VETLYIDEAF ACHAGTLRAL IAIIRPKKAV LCGDPKQCGF FNMMCLKVHF NHEICTQVFH 

       850        860        870        880        890        900 
KSISRRCTKS VTSVVSTLFY DKRMRTTNPR DSKIEIDTTG STKPKKDDLI LTCFRGWVKQ 

       910        920        930        940        950        960 
LQIDYKGNEI MTAAASQGLT RKGVYAVRYK VNENPLYAPT SEHVNVLLTR TEDKIVWKTL 

       970        980        990       1000       1010       1020 
AGDPWIKTLT AKYPGDFTAT MEEWQAEHDA IMRHILEKPD PTDVFQNKAN VCWAKALVPV 

      1030       1040       1050       1060       1070       1080 
LKTAGIDLTT EQWNTVDYFK EDKAHSAEIV LNQLCVRFFG LDLDSGLFSA PTVPLSIRNN 

      1090       1100       1110       1120       1130       1140 
HWDNSPSPNM YGLNKEVVRQ LSRRYPQLPR AVTTGRAYDM NTGTLRNYDP RINLVPVNRR 

      1150       1160       1170       1180       1190       1200 
LPHALVTQHA DYPPSDFSAF VSKLKGRTVL VVGEKMSISG KTVDWLSETP DSTFRARLDL 

      1210       1220       1230       1240       1250       1260 
GIPSELPKYD IVFVNVRTQY RYHHYQQCED HAIKLSMLTK KACLHLNPGG TCVSIGYGYA 

      1270       1280       1290       1300       1310       1320 
DRASESIIGA VARQFKFSRV CKPKVSKEET EVLFVFIGFD RKTRTHNPYK LSSTLTNIYT 

      1330       1340       1350       1360       1370       1380 
GSRLHEAGCA PSYHVVRGDI ATATEGVIVN AANSKGQPGS GVCGALYRKY PESFDLQPIE 

      1390       1400       1410       1420       1430       1440 
VGKARLVKGN SKHLIHAVGP NFNKVSEVEG DKQLAEAYES IARIINDNNY RSVAIPLLST 

      1450       1460       1470       1480       1490       1500 
GIFAGNKDRL MQSLNHLLTA LDTTDADVAI YCRDKKWEVT LKEVVARREA VEEICISEDS 

      1510       1520       1530       1540       1550       1560 
SVAEPDAELV RVHPKSSLAG RKGYSTSDGK TFSYLEGTKF HQAAKDMAEI NAMWPAATEA 

      1570       1580       1590       1600       1610       1620 
NEQVCLYILG ESMSSIRSKC PVEESEASTP PSTLPCLCIH AMTPERVQRL KASRPEQITV 

      1630       1640       1650       1660       1670       1680 
CSSFPLPKYR ITGVQKIQCS HPILFSPKVP EYIHPRKYLA DAASANNEAA ELTSVDVQPQ 

      1690       1700       1710       1720       1730       1740 
LEESPENTEQ LVEEEDSISV LSEAPHQVHQ VEAEVHRFSA SAQSSSWSIP RASDFDVESL 

      1750       1760       1770       1780       1790       1800 
SVLESLGAND TISMESSSNE TALALRTIFR TPPIPRPRVQ STSTDVDSIS ALESCDSTSD 

      1810       1820       1830       1840       1850       1860 
ARSVDSDETD VSIFDKRLEF MARPVPAPRT KFRTPPVPKP RARRPFHPLS SRSSSRSSLA 

      1870       1880       1890       1900       1910       1920 
SNPPGVNRVI TREEFEAFVA QQQRFDAGAY IFSSDTGQGH LQQKSVRQTV LSEVVLERTE 

      1930       1940       1950       1960       1970       1980 
LEISYAPRLD LNKEEILRKK LQLNPTQANR SRYQSRRVEN MKAITTKRIL QGLGHYLKSE 

      1990       2000       2010       2020       2030       2040 
GKVECYRTLH PVPLYSASVN RAFSSPKVAV EACNVVLKEN FPTVASYCII PEYDAYLDMV 

      2050       2060       2070       2080       2090       2100 
DGASCCLDTA SFCPAKLRSF PKKHAYLEPT IRSAVPSAIQ NTLQNVLAAA TKRNCNVTQM 

      2110       2120       2130       2140       2150       2160 
RELPVLDSAA FNVECFKKYA CNNEYWETYK KNPIRLTEEN VVNYITKLKG PKAAALYAKT 

      2170       2180       2190       2200       2210       2220 
HNLDMLQDIP MDRFIMDLKR DVKVTPGTKH TEERPKVQVI QAADPLATAY LCGIHRELVR 

      2230       2240       2250       2260       2270       2280 
RLNAVLLPNI HTLFDMSAED FDAIIAEHFQ PGDWVLETDI ASFDKSEDDA MALTALMILE 

      2290       2300       2310       2320       2330       2340 
DLGVDPELLT LIEAAFGEIS SIHLPTKTKF RFGAMMKSGM FLTLFVNTVI NMVIASRVLR 

      2350       2360       2370       2380       2390       2400 
ERLTNSPCAA FIGDDNIVKG VKSDKLMADR CATWLNMEVK IIDAVVGEKA PYFCGGFILC 

      2410       2420       2430       2440       2450       2460 
DSVTGTACRV ADPLKRLFKL GKPLAVDDEH DDDRRRALQE ESARWNRVGI FSELCKAVES 

      2470       2480       2490 
RYETVGTAVI IMAMTTLASS VESFSCLRGA PIALYG 

Q8V294 in FASTA format

View entry in original UniProtKB/Swiss-Prot format
View entry in raw text format (no links)
Report form for errors/updates in this UniProtKB/Swiss-Prot entry

BLAST logo BLAST submission on ExPASy/SIB
or at NCBI (USA)
Tools Sequence analysis tools: ProtParam, ProtScale, Compute pI/Mw, PeptideMass, PeptideCutter, Dotlet (Java)
PROSITE logo ScanProsite, MotifScan SWISS-MODEL Submit a homology modeling request to SWISS-MODEL
NPSA logo NPSA Sequence analysis tools

ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
 Hosted by au flag APAF Australia Mirror sites: Brazil  Canada  China  Korea  Switzerland
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!